Medical Marijuana Patients In Germany Benefit from 50% Price Reduction Thanks To Legalization, New Report
Medical marijuana company Bloomwell Group GmbH released a report Wednesday on Germany’s private medical marijuana market. The Frankfurt-based company serves as the centralized digital infrastructure for medical cannabis distribution, consultations and treatment including via telemedicine and dispensing. The analysis comes after major cannabis reform in Germany with the implementation of the Cannabis Act (CanG).
When partial cannabis legalization took effect in Germany on April 1, it allowed adults over 18 to legally possess up to 25 grams of dried cannabis and cultivate up to three plants at home. One of the biggest breakthroughs under the law is that medical cannabis is essentially regulated like ibuprofen.
What else changed since then? Per the report, the price for medical marijuana flower initially rose slightly following its reclassification as a non-narcotic. However, costs quickly stabilized and then dropped in June. More importantly, patients are now paying an average of half the price for medical marijuana prescriptions, compared to what they paid at the beginning of 2023.
“Through the Bloomwell platform, which is by far the largest of its kind in Europe, we have been able to gather and analyze a …